BPG is committed to discovery and dissemination of knowledge
Randomized Clinical Trial
Copyright: ©Author(s) 2026.
World J Psychiatry. Jul 19, 2026; 16(7): 118770
Published online Jul 19, 2026. doi: 10.5498/wjp.118770
Table 1 Distribution of participants according to socio-demographic characteristics (n = 68), mean ± SD
Characteristics
Experimental group (n = 34)
Control group (n = 34)
Test value and significance
Gender
Female823.51132.4χ2 = 0.292, P = 0.589
Male2676.52367.6
Marital status
Single2367.62779.4χ2 = 0.680, P = 0.410
Married1132.4720.6
Diagnosis
Bipolar disorders926.5823.5χ2 = 0.000, P = 1.000
Schizophrenia and other psychotic disorders2573.52676.5
Income status
Income less than expenses1647.11029.4χ2 = 2.455, P = 0.336
Income equal to expenses1441.21750.0
Income more than expenses411.7720.6
Educational status
Literate823.5617.6χ2 = 1.363, P = 0.739
Primary education1029.41132.4
Secondary education1235.31544.1
Bachelor’s degree411.825.9
Employment status
Unemployed2367.62264.7χ2 = 0.216, P = 1.000
Employed720.6720.6
Retired411.8514.7
Age40.32 ± 9.1541.06 ± 8.71t = -0.339, P = 0.735
Years of smoking23.71 ± 9.8623.68 ± 8.78t = 0.013, P = 0.990
Table 2 Daily cigarette consumption by group across time, n (%)
Time point
Cigarettes/day
Experimental group
Control group
Pretest00 (0)0 (0)
1-103 (8.8)4 (11.8)
11-2010 (29.4)11 (32.4)
21-3010 (29.4)8 (23.5)
≥ 3111 (32.4)11 (32.4)
Posttest06 (17.6)0 (0)
1-10 4 (11.8)3 (8.8)
11-2011 (32.4)11 (32.4)
21-309 (26.5)11 (32.4)
≥ 314 (11.8)9 (26.5)
1st follow-up05 (14.7)0 (0)
1-104 (11.8)3 (8.8)
11-209 (26.5)10 (29.4)
21-3010 (29.4)12 (35.3)
≥ 316 (17.6)9 (26.5)
2nd follow-up04 (11.8)0 (0)
1-104 (11.8)3 (8.8)
11-209 (26.5)11 (32.4)
21-3010 (29.4)10 (29.4)
≥ 317 (20.6)10 (29.4)
Table 3 Two-way repeated measures analysis of variance results for Fagerström Test for Nicotine Dependence, Smoking Self-Efficacy Questionnaire, and cigarettes per day, mean ± SD
Time point
Experimental group
Control group
Time
Group
Group × time
FTNDF = 8.36F = 3.95F = 3.21
Pretest16.76 ± 1.396.91 ± 1.71P = 0.001 P = 0.051P = 0.049
Posttest25.03 ± 2.906.56 ± 1.89η2 = 0.112 η2 = 0.057η2 = 0.046
1st follow-up35.41 ± 2.856.47 ± 1.89Post hoc: 1 > 2, 1 > 3
2nd follow-up45.59 ± 2.796.59 ± 2.03
CPDF = 3.40F = 2.69F = 3.72
Pretest123.29 ± 8.9822.82 ± 9.62P = 0.019P = 0.106P = 0.012
Posttest216.15 ± 10.8223.15 ± 9.37η2 = 0.049η2 =0.053
1st follow-up318.24 ± 12.2022.3 ± 9.06Post hoc: 1 > 2
2nd follow-up419.68 ± 11.7022.53 ± 9.61
SEQF = 14.72F = 5.63F = 22.41
Pretest150.59 ± 20.3651.50 ± 16.48P < 0.001P = 0.021P < 0.001
Posttest269.74 ± 19.2449.47 ± 13.65η2 = 0.182η2 = 0.079η2 = 0.254
1st follow-up360.59 ± 20.4150.26 ± 15.26Post hoc: 1 < 2, 1 < 3, 2 > 3, 2 > 4
2nd follow-up458.62 ± 19.7250.38 ± 15.24


Write to the Help Desk